Johnson, Bryon D.
Medical College of Wisconsin
4 papers on CoChatORCID 0000-0001-7416-3396
Most cited papers
- Verified
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
Shah, N. N., Johnson, B. D., Schneider, D., Zhu, F., Szabo, A., Keever-Taylor, C. A., Krueger, W., Worden, A. A., Kadan, M. J., Yim, S., et al. (2020) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 468
- Verified
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
Tsai, S., McOlash, L., Palen, K., Johnson, B., Duris, C., Yang, Q., Dwinell, M. B., Hunt, B., Evans, D. B., Gershan, J., et al. (2018) · BMC Cancer
Pancreatic and Hepatic Oncology ResearchCancer Cells and Metastasis
Cited by 400
- Verified
Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
Hallett, W. H. D., Jing, W., Drobyski, W. R., & Johnson, B. D. (2011) · Biology of Blood and Marrow Transplantation
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 152
- Verified
STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer
Vonderhaar, E. P., Barnekow, N. S., McAllister, D., McOlash, L., Eid, M. A., Riese, M. J., Tarakanova, V. L., Johnson, B. D., & Dwinell, M. B. (2021) · Cellular and Molecular Gastroenterology and Hepatology
interferon and immune responsesPancreatic and Hepatic Oncology Research
Cited by 61
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free